TotalMarketCap

Nuvation Bio

NUVBNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.511 B

$4.28 -9.51%

Close of 6 Nov 2026

As of 6 Nov 2026, Nuvation Bio (NUVB) has a market capitalization of $1.51B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$62.9M

#2643 by revenue

Earnings

-$204.6M

Loss-making

Shares outstanding

353,017,638

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #111Braveheart BioBRVE$1.57B
  2. #112NanobiotixNBTX$1.52B
  3. #113Nuvation BioNUVB$1.51B
  4. #114PrecigenPGEN$1.50B
  5. #115uniQureQURE$1.47B

What if Nuvation Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$79,987.15

Per share 18,689× higher

Bitcoin $1.53T

$4,327.97

Per share 1,011× higher

Apple $5.02T

$14,208.31

Per share 3,320× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Nuvation Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.